Business news

Hepatitis Rapid Testing Market to Witness Tremendous Growth Due to COVID-19 Pandemic

According to Fact MR’s latest research, the hepatitis rapid testing market will grow at a significant rate of XX percent between 2021 and 2031, with a CAGR of XX percent. Increased demand for hepatitis rapid testing as a result of the high prevalence of hepatitis infections, as well as increased awareness of available treatments and procedures, could propel this market forward.

What’s Driving Hepatitis Rapid Testing Demand?

Hepatitis, which is defined as inflammation or damage to the liver, affects the functions of the liver, which include nutrient processing, blood filtering, and infection defence. Hepatitis A, which is caused by one of five viruses and can be cured, is common in many countries.

Hepatitis B (HBV) and C (HCV), on the other hand, are commonly associated with liver transplants and liver cancer. HBV and HCV can cause serious health problems such as liver cirrhosis, liver failure, cancer, and even death if not detected early. If left untreated, patients, particularly those with compromised immune systems, may not be able to recover from viral infections.

Since medication and treatment for hepatitis A and B are available, regular testing for hepatitis C infections, both acute and chronic, is recommended. Individuals infected with the hepatitis C virus will be able to take preventative measures before receiving lifesaving treatment. This will also aid in determining the extent of liver damage as well as other health issues that may arise as a result of infection, thereby preventing virus transmission to others.

According to World Health Organization (WHO) updates for 2021, approximately 58 million people worldwide are infected with the hepatitis C virus, with nearly 1.5 million new cases of infection occurring each year.

Opportunities for Hepatitis Rapid Testing Market Technological Advancements

With the help of technology and extensive research on the viruses that cause hepatitis, particularly HCV, various effective antiviral drugs and diagnostic devices have been developed to treat HCV infections. The development of new technologies to measure the viral load in infected patients, as well as improved therapeutic options for infection management, have significantly increased the market potential for hepatitis rapid testing.

Rapid diagnostics tests are gaining traction in the field of hepatitis rapid testing, as they allow for the diagnosis of acute infections as well as the confirmation of chronic cases of hepatitis, allowing for prompt treatment of infected patients.

For List of Key Players and Full Segmentation, Ask for a Sample Report –

To Top

Pin It on Pinterest

Share This